Ilika Plc · LSE:IKA
Ilika — H1 2024 Earnings Presentation
21 slides from Ilika's earnings presentation, January 2024
Slide 1: Ilika – Half Year Results
Ilika – Half Year Results January 2024
Slide 2: Disclaimer
Disclaimer The materials being provided to you in connection with this presentation are strictly confidential and intended only for informational purposes and convenient reference. This document has been prepared by Ilika plc (“Ilika”) and is the responsibility of the same and comprises the written
Slide 3: Ilika at a Glance
Ilika at a Glance Pioneer in Solid State Batteries (SSBs) Product lines: Stereax miniature cells used primarily to power miniature medical devices and industrial IoT Goliath large format cells targeting the automotive industry and cordless consumer appliances Developing SSBs for EV use with
Slide 4: Seasoned Management Team
Seasoned Management Team Management Team and Board Offer a Wealth of Diversified Experience Across Multiple Industries Graeme Purdy Jason Stewart Jeremy Millard Monika Biddulph Keith Jackson Chief Executive Officer & Co- Chief Financial Officer Non-Executive Director Non-Executive Director Chairman
Slide 5: Ilika Business Model
Ilika Business Model Asset-light licensing model demonstrated on production-intent equipment Company Stereax Goliath ESG Finances Outlook 5 Overview
Slide 6: Stereax: Ilika’s Unique Miniature Battery
Stereax: Ilika’s Unique Miniature Battery Stereax Technology is Capable of Revolutionising the Medical Implant Industry Reduced Surgical Intervention: compact architecture offers higher energy density enabling smaller device designs Improved Safety: no toxic fluid leakage possible Higher Power Densi
Slide 7: Stereax: Designed for a Burgeoning Market
Stereax: Designed for a Burgeoning Market Powering the Electroceutical Revolution Demand for Medical Batteries to Being Driven by Innovation in Electroceuticals and Sensors Smart surgical Smart contact Smart Neuromodulation Implanted sensors Smart orthopedics instruments lenses orthodonctic Projecte
Slide 8: Stereax: Commercial Order Analysis
Stereax: Commercial Order Analysis Initial commercial orders from a US-centric customer base 21 24 Companies Orders Company Stereax Goliath ESG Finances Outlook 8 Overview
Slide 9: Stereax: Commercial Growth
Stereax: Commercial Growth Income growth from Stereax product will be derived Customer interest remains strong with continued engagement from several revenue streams which build as market from existing customers penetration increases Company Intended Application Sector Size & Customer D Customer Typ
Slide 10: Stereax: Cirtec Partnering
Stereax: Cirtec Partnering Cirtec Medical: an industry-leading Status: key equipment sets vertically-integrated outsource transferred to Cirtec, commissioning partner for medical devices and proceeding. components Partnership Benefits to Ilika: Validation: of Stereax product and process Manufacturin
Slide 11: Ilika’s Cutting Edge Solid State EV Battery
Goliath: Ilika’s Cutting Edge Solid State EV Battery Goliath’s Technology is Capable of Revolutionizing the EV Industry with High Performance Batteries Further Range: Oxide electrolyte and silicon anode architecture offer higher energy density v LiB and so better range/weight Improved Safety: Solid-
Slide 12: Target Market and Other Key Market Drivers
Goliath: Target Market and Other Key Market Drivers Ilika’s Unique Position to Service a Fast Growing Market Electrification of Transportation and Net-Zero Initiatives • 19 national governments have committed to attaining net-zero emission by 2050 • Transportation remains one of the highest emitting
Slide 13: Addressable Sector
Goliath: Addressable Sector 2023 BNEF EV outlook projects EV sales to be 44% of global vehicle sales by 2030 and 75% by 2040 Ilika Targets Luxury Performance Market 1,400 Goliath Market Energy 1,200 Point TAM 50GWh/a 1,000 Cell Energy (Wh/I) 800 600 400 7-Feb-24 Page 13 200 Cell Cost ($/kWh) 0 0 50
Slide 14: Technology Roadmap and Production Scale-Up
Goliath: Technology Roadmap and Production Scale-Up Solid-State Battery Energy Density Ilika Scale-up Plan and Business Model 2023/5 Highlights 2025/6 Highlights • 2023: D4 design freeze of multi-layer pouch cells followed by lithium-ion • Testing electrode printing at near Giga scale parity. • Deve
Slide 15: Solid-State Battery Technology Landscape
Goliath: Solid-State Battery Technology Landscape Different chemistries are optimal for different applications Oxide Electrolyte Sulfide Electrolyte Polymer Electrolyte Si anode 5 2 2 3 11 3 Li anode Anode- 1 less Chemistry Sulfide Electrolyte Oxide Electrolyte Polymer Electrolyte Lithium Anode Sili
Slide 16: Partnerships for Technology Deployment
Goliath: Partnerships for Technology Deployment Ilika has Entered Critical Partnerships to Fast Track Commercialization of Goliath Faraday Battery Challenge Round 5: HISTORY • A 24-month FBC Collaborative R&D programme • Duration: 1 Feb 23 until 31 Jan 25 • Total programme value: £8M/Ilika grant £2.
Slide 17: Partnering for Manufacturing Scale-up
Goliath: Partnering for Manufacturing Scale-up Ilika is receiving support from the Automotive Transformation Fund ATF SuRV2: SiSTEM 17-months from Oct 2023 Programme value £2.7m/£400k Ilika grant funding Objectives: • Undertake physical trials of Ilika’s electrode production at UKBIC • Design, build
Slide 18: Commercial Interaction Analysis
Goliath: Commercial Interaction Analysis Strongest demand from European automotive OEMs 17 Companies Company Stereax Goliath ESG Finances Outlook 18 Overview
Slide 19: ESG
ESG ESG is of utmost importance to Ilika and is monitored at board level We continue to remain ahead of reporting requirements through our commitment to ESG Benchmarking ESG Materiality ESG Policy Internal Target ESG Monitoring against Committee Assessment Statement Setting Framework and Reporting s
Slide 20: Finances
Finances Ilika Plc, un-audited financial results for the half-year ending 31 October 2023 Total Income £1.3m (H1 2023: £0.2m) o Substantial increase due to HISTORY grant, supporting Goliath. o Income from grants of £1.3m (H1 2023: £0.2m) o Lower income expected in second half due to phasing. o HISTO
Slide 21: Outlook
Outlook Scale Stereax through joint manufacturing and marketing with Cirtec Mature Goliath technology with partners through defined technical milestones Continue pursuing grant support and commercial revenue through partnering Commercial opportunity continues to build for Ilika's technology across t